lower risk – Page 3 – Communicable Diseases Research

Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant

델타 변종에 대한 코로나바이러스 질병 2019(COVID-19) 백신의 비교 효과

Comparative Study

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종,

The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19

COVID-19로 입원한 환자의 사망률 및 자원 활용에 대한 변이체 및 백신 접종의 영향

Observational Study

Published on 2022-08-222022-09-11
Journal: BMC Infectious Diseases [Category] 변종, 임상,

[키워드] Admission adult COVID-19 patient adult COVID-19 patients adults hospitalized affected age association changed Community community health community health system Comorbidities COVID pneumonia COVID-19 Delta demographics Duration emerging diseases group Health health system healthcare Healthcare utilization Hospitalized hospitalized patient hospitalized patients immunization Inpatient less lower risk lowest medical record Mortality Multimorbidity multiple comorbidities multiple comorbidity observational study omicron outcome pandemic Patient patients hospitalized Pneumonia protective effect Public public health remained resource retrieved risk factor therapy vaccination vaccine availability variant variants virus variants with COVID-19 younger patients
[DOI] 10.1186/s12879-022-07657-z PMC 바로가기 [Article Type] Observational Study

Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?

소아 인구에 적절한 예방 접종 범위가 없으면 COVID 전염병에서 벗어날 수 있습니까?

Article

Published on 2022-08-192022-09-11
Journal: Italian Journal of Pediatrics [Category] SARS, 변종, 치료기술,

[키워드] age all subjects approved booster Can children contrary Coverage COVID COVID-19 COVID-19 incidence COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death delta variant diagnosed diffusion dose epidemiological epidemiological surveillance Epidemiology evidenced explain General population greater groups Hospitalization Infant Infection Infectious diseases Italy lower risk manuscript minor nucleic acid Older pandemic pediatric Pediatric case pediatric cases pediatric cohort Pediatric infectious diseases Population positive prolongation proportion rapid increase real-time reverse-transcriptase polymerase-chain-reaction recorded recruited remained RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid severe disease significant increase specimen subject Surveillance susceptible vaccination vaccine dose virus
[DOI] 10.1186/s13052-022-01339-x PMC 바로가기 [Article Type] Article

AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial

Clinical Trial

Published on 2022-08-162022-10-04
Journal: Frontiers in Public Health [Category] SARS, 임상, 진단,

[키워드] Analysis Anu AYURAKSHA kit Ayurveda Blood blood sugar C-reactive protein CD3 CD4 CD8 clinical control group controls COVID-19 COVID-19 crisis COVID-19 infection COVID-19 pandemic determine distribution dysregulated effective Efficacy effort erythrocyte sedimentation rate evaluated hematological hematological parameter hematological parameters IgG IgG positivity IL-6 IL-6 level Immunity incidence India Infection inflammation marker Intervention life lower risk Lymphocyte subset management Medicine Mortality no increase non-randomized pandemic participant Participants post-intervention Primary outcome Prophylactic Quality Quality of life Quality of life (QoL) random reduced reducing Research secondary outcome severity of COVID-19 significantly significantly lower status the WHO Trial Version
[DOI] 10.3389/fpubh.2022.920126 PMC 바로가기 [Article Type] Clinical Trial

Patients with CLL have a lower risk of death from COVID-19 in the Omicron era

CLL 환자는 오미크론 시대에 COVID-19로 인한 사망 위험이 더 낮습니다

Article

Published on 2022-08-042022-09-11
Journal: Blood [Category] SARS, 변종,

[키워드] 30-Day mortality acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission age antiviral therapy chronic lymphocytic leukemia CLL Cohort cohort of patient Comorbidity Contact coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death declined described disease course dominance General population high mortality hospital Hospitalization hospitalizations Immunocompromised Immunocompromised patient Immunocompromised patients intensive care leukemia lower risk Lymphocytic leukemia omicron Omicron variant outcome Patient population-based cohort positive Previous studies previous study remained reported SARS-CoV-2 SARS-CoV-2 test severe acute respiratory syndrome Coronavirus shown significantly tested variant
[DOI] 10.1182/blood.2022016147 PMC 바로가기 [Article Type] Article

ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms

ABO 혈액형 및 COVID-19와의 연관성: 보고된 연관성 및 가능한 기본 메커니즘에 대한 포괄적인 검토

Review

Published on 2022-08-012022-09-11
Journal: Microbial pathogenesis [Category] COVID19(2023년), SARS, 유전자 메커니즘,

[키워드] ABO ABO antibodies ABO blood Group system ABO blood type ABO blood types Affect antibodies Antigen association associations Blood Blood Group blood group system blood type cells COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients COVID-19 severity described Disease progression disease severity disease transmission Diseases explain facilitate genetic association genetic associations glycobiology glycoprotein group higher risk Host hypothese implication Infectious diseases Interaction locus lower risk management mechanism Mortality natural history outcome outcomes progression protective effect protective factor reported risk risk factor risk of infection SARS-CoV-2 SARS-COV-2 infection severity Structure susceptibility the disease thromboembolic Thromboembolic event Thromboembolic events Transmission transmitted with COVID-19
[DOI] 10.1016/j.micpath.2022.105658 PMC 바로가기 [Article Type] Review

Incidence and Clinical Features of Pneumomediastinum and Pneumothorax in COVID-19 Pneumonia

Observational Study

Published on 2022-08-012022-10-05
Journal: Journal of Intensive Care Medicine [Category] 임상,

SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination

Comirnaty® COVID-19 백신 접종 후 중간에 요양원 거주자의 SARS-CoV-2 Delta 변이형 돌발 감염

Article

Published on 2022-08-012022-09-11
Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus anti-RBD Anti-spike anti-spike antibodies antibody Antibody Response Antibody responses assays Breakthrough infection breakthrough infections Chain Reaction characterized Comirnaty® COVID-19 vaccine Community coronavirus COVID-19 COVID-19 vaccination COVID-19 vaccine Delta delta variant determined by develop diagnosis of SARS-CoV-2 female flow cytometry Frequency Hospitalization infected with SARS-CoV-2 Infection lateral flow lower risk median median age naïve nasopharyngeal specimen nine nursing home nursing home residents nursing homes occurred participant Participants plasma polymerase chain polymerase chain reaction positive prior diagnosis quantified Quantitative respiratory RNA loads SARS-CoV-2 SARS-CoV-2 Delta variant SARS-COV-2 infection SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Spain spike-reactive T cells. T cell T cells tested vaccination Valencian
[DOI] 10.1002/jmv.27799 PMC 바로가기 [Article Type] Article

Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants

유아의 SARS-CoV-2 감염 발생률과 임신 중 COVID-19 예방 접종의 연관성

Article

Published on 2022-08-012022-09-11
Journal: JAMA Internal Medicine [Category] Fulltext, SARS, 변종,

[키워드] 95% CI adjusted hazard ratio age Birth Chain Reaction cohort study country COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Cox proportional hazard regression Delta delta variant determine dose during pregnancy Follow-up hazard ratio incidence rate Infant Infants life lower risk Maternal maternal age Messenger RNA mother Norway omicron Omicron variant outcome parity polymerase chain polymerase chain reaction population-based cohort positive Positive test Pregnancy pregnant women provide receive reduce reduced risk residence risk SARS-CoV-2 severe COVID-19 stratified suggested test result vaccination Vaccination Status variant variants was used women
[DOI] 10.1001/jamainternmed.2022.2442 PMC 바로가기 [Article Type] Article

Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic

코로나19 팬데믹 기간 동안 이탈리아 선천성 면역질환 환자의 단클론항체 및 항바이러스제 실생활 데이터

Article

Published on 2022-07-282022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료제,

[키워드] Alpha Analysis Antiviral antiviral agent Antiviral agents antiviral drug antiviral drugs Asymptomatic Care circulating Cohort contributed Course COVID-19 COVID-19 pandemic COVID-19 severity disease disease severity duration of viral shedding Effect Efficacy error evaluated Hospital admission Hospitalization hospitalization-risk hospitalizations hospitalized patients ICU admission Immunity immunized Inborn Inborn errors inborn errors of immunity Infection Italian longitudinal lower risk mAbs mitigate monoclonal monoclonal antibodies monoclonal antibody Mortality mRNA vaccine mRNA vaccines offered Patient patients treated performed positive Prevent prophylactic measure prophylactic measures Re-infection Re-infections reduce reduced Reinfection reported respond risk Safe SARS-CoV-2 SARS-CoV-2 infected patients SARS-CoV-2 positivity SARS-CoV-2 strains SARS-CoV-2 virus severe COVID-19 severe disease Spectrum Spread Strains therapeutic therapy treated vaccination Vaccinations Viral viral shedding viral strain viral strains widespread
[DOI] 10.3389/fimmu.2022.947174 PMC 바로가기 [Article Type] Article